Impact of safety-related regulatory action on clinical practice: a systematic review.
about
Automatic detection of adverse events to predict drug label changes using text and data mining techniques.Implementation of warnings from Dear Doctor Letters (Rote-Hand-Briefe): an analysis of medication data from a large cohort of elderly patientsThe effectiveness of risk communication regarding drug safety information: a nationwide survey by the Japanese public health insurance claims data.Stimulated reporting: the impact of US food and drug administration-issued alerts on the adverse event reporting system (FAERS)The increase in prescriptions of bisphosphonates and the incidence proportion of osteonecrosis of the jaw after risk communication activities in Japan: a hospital-based cohort studyPrescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trialEvaluating the effectiveness of risk minimisation measures: the application of a conceptual framework to Danish real-world dabigatran data.Prescription behavior for gastroprotective drugs in new users as a result of communications regarding clopidogrel - proton pump inhibitor interaction.The Weber effect and the United States Food and Drug Administration's Adverse Event Reporting System (FAERS): analysis of sixty-two drugs approved from 2006 to 2010.Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome.Impact of Safety-Related Regulations on Codeine Use in Children: A Quasi-Experimental Study Using Taiwan's National Health Insurance Research Database.Patient and Physician Perceptions of Drug Safety Information for Sleep Aids: A Qualitative Study.Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem-containing medications.Pharmaceutical Benefit-Risk Communication Tools: A Review of the Literature.Non-steroidal anti-inflammatory drug administration after coronary artery bypass surgery: utilization persists despite the boxed warning.The Additional Value of an E-Mail to Inform Healthcare Professionals of a Drug Safety Issue: A Randomized Controlled Trial in the Netherlands.The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist.Impact of rosiglitazone safety alerts on oral antidiabetic sales trends: a countrywide study in Portugal.The effectiveness and limitations of regulatory warnings for the safe prescribing of citalopram.Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan.Assessment of the impact of scheduled postmarketing safety summary analyses on regulatory actions.Focusing on risk communication about medicines: why now?Evaluation of two Japanese regulatory actions using medical information databases: a 'Dear Doctor' letter to restrict oseltamivir use in teenagers, and label change caution against co-administration of omeprazole with clopidogrel.The Impact of US FDA and Health Canada Warnings Related to the Safety of High-dose Simvastatin.Long-Run Trends in Antidepressant Use Among Youths After the FDA Black Box Warning.Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs.Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.Health regulatory communications of well-established safety-related pharmacogenomics associations in six developed countries: an evaluation of alignment.Impact of an intervention on the prescription of aliskiren after new evidence on safety reported.Listen to the public and fulfil their information interests - Translating vaccine communication research findings into guidance for regulators.Safety Communication Tools and Healthcare Professionals' Awareness of Specific Drug Safety Issues in Europe: A Survey Study.Risk Communication and the Pharmaceutical Industry: what is the reality?Media Coverage of FDA Drug Safety Communications about Zolpidem: A Quantitative and Qualitative Analysis.
P2860
Q30660881-07929168-9EE3-43F8-8186-1A9D2E2F59FAQ30810766-93FCBED8-A3D6-4186-A844-1A586BF2389DQ30907640-45C6E532-1E7C-4E94-A4AF-CD7776B6A6BBQ34389980-3C97DD11-C1A2-475F-BF59-A4D583EA7FC1Q34503444-0B9F8C6C-FA2E-4124-920F-9205B1EB1F67Q35595713-7935F96A-AF33-494B-B18F-234D4606849DQ36342841-B54C1F88-99B2-42AE-B76F-88964F3F88D0Q37591802-8216E0C8-F76E-4BBB-87DF-0AA23AF94961Q37683523-219B0B95-A8CD-48AE-B7BD-02D8B0EA7F6AQ38691137-581386A2-7E5D-487B-940C-EC27921FF169Q38737370-73C179C3-AE75-4FE7-AF11-EA7D26749067Q38752166-D656B239-33CB-4AE0-AD00-0DCCC414270FQ38816487-07171D27-8987-4793-B88C-0B27779550DDQ38981425-A3844069-58AD-4C5B-BA47-DCE2DAECC707Q39014657-D505FF34-9989-420D-90EE-B17DCBEC27ECQ39397168-6D2E8C82-A50D-4C97-A7EE-92CA30114934Q39422837-6A7B92E2-2838-4663-BBD0-61A4A04CE7A2Q39711572-D0ABC286-2A4C-4CCC-B3AA-E3BC5681F6D8Q40597331-D459241E-531D-4AF2-A25A-88E44E72A3ACQ40649706-CED8757A-3947-4AF2-A2A5-45182BF7B640Q40924344-AC730949-3512-4846-B6E5-F1F9EC2C8F1DQ43237199-4962AF11-A14A-4AF1-8AD7-AAFA7B93D7A9Q43828480-35698400-A4CB-4E2A-A8AE-810825CF2995Q47110995-39A28926-8505-4977-A1CF-F3A4C64B1201Q47309145-DCDF8788-C854-46E6-8249-1F5DD90D7653Q47619604-B8A9EDFA-30B7-4154-920D-6159AC9CEACDQ47653552-3518DAB1-5CF0-4DAB-A0BC-9F272A0F0048Q48861311-94569022-C8E4-43D4-B79D-573DBD11E912Q51061508-A642700C-A7F6-4856-A384-006764208F9FQ52638852-3EE4F4B5-01F3-4898-86BB-D8D724452C02Q52676212-E099D688-EDA9-419B-8D6A-CEBE3B8FA789Q53122388-2325411F-6125-4F0B-A730-B8F1527A9735Q53403274-C4CE5E14-7BDE-43E6-8D4D-D2B4FA996B52
P2860
Impact of safety-related regulatory action on clinical practice: a systematic review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Impact of safety-related regulatory action on clinical practice: a systematic review.
@en
type
label
Impact of safety-related regulatory action on clinical practice: a systematic review.
@en
prefLabel
Impact of safety-related regulatory action on clinical practice: a systematic review.
@en
P2093
P2860
P1433
P1476
Impact of safety-related regulatory action on clinical practice: a systematic review
@en
P2093
Flora M Haaijer-Ruskamp
Jonie T N de Vries
Menno E van der Elst
Pieter A de Graeff
Sabine M J M Straus
Sigrid Piening
P2860
P304
P356
10.2165/11599100-000000000-00000
P50
P577
2012-05-01T00:00:00Z
P5875
P6179
1012305707